These emerging treatments, Tirzepatide , represent a remarkable advancement in treating obesity and conceivably other ailments . They are categorized as GLP-1 hormone activators , meaning these substances to emulate the body's GLP-1 substance , enhancing insulin production and suppressing appetite . While Retatrutide each functions somewhat similar